Subtype-selective GABAA receptor modulation yields a novel pharmacological profile: the design and development of TPA023
JR Atack - Advances in Pharmacology, 2009 - Elsevier
Abstract TPA023 is a GABA A α2/α3 subtype-selective modulator which in preclinical
species has anxiolytic-like activity but does not produce sedative-like properties and is …
species has anxiolytic-like activity but does not produce sedative-like properties and is …
Subtype-selective GABA (A) receptor modulation yields a novel pharmacological profile: the design and development of TPA023
JR Atack - Advances in pharmacology (San Diego, Calif.), 2009 - pubmed.ncbi.nlm.nih.gov
TPA023 is a GABA (A) alpha2/alpha3 subtype-selective modulator which in preclinical
species has anxiolytic-like activity but does not produce sedative-like properties and is …
species has anxiolytic-like activity but does not produce sedative-like properties and is …
Subtype-selective GABA (A) receptor modulation yields a novel pharmacological profile: the design and development of TPA023.
JR Atack - Advances in Pharmacology (San Diego, Calif.), 2009 - europepmc.org
TPA023 is a GABA (A) alpha2/alpha3 subtype-selective modulator which in preclinical
species has anxiolytic-like activity but does not produce sedative-like properties and is …
species has anxiolytic-like activity but does not produce sedative-like properties and is …
Subtype-Selective GABAA Receptor Modulation Yields a Novel Pharmacological Profile: The Design and Development of TPA023
JR Atack - Contemporary Aspects of Biomedical Research: Drug …, 2009 - books.google.com
TPA023 is a GABAA a2/a3 subtype-selective modulator which in preclinical species has
anxiolytic-like activity but does not produce sedative-like properties and is without abuse …
anxiolytic-like activity but does not produce sedative-like properties and is without abuse …